Status:
COMPLETED
New Versus Existing Auto-titrating CPAP Device to Treat Obstructive Sleep Apnea in Adults
Lead Sponsor:
Compumedics Limited
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) is a condition of disordered breathing characterised by intermittent partial and/or complete upper airway obstruction during sleep. The participants, naive to nasal conti...
Detailed Description
Auto-titrating CPAP (APAP) using algorithms based on detection of flow limitation and snoring have been developed. Auto-titration devices adjust nasal pressure to the minimum pressure needed to mainta...
Eligibility Criteria
Inclusion
- Age greater than 18.
- Ability to give informed consent.
- OSA diagnosis and referral for clinical CPAP implementation at the Monash Sleep Centre within 3 months of recruitment.
Exclusion
- Inability to give informed consent.
- Significant central sleep apnea (AHI for central events \>= 5).
- Congestive heart failure.
- Co-existing obesity related hypoventilation.
- Nasal obstruction, mouth breathing or other anatomical or physiological conditions making CPAP therapy inappropriate.
- History of prior CPAP treatment.
- Previous reaction to skin preparation, tapes and electrode gels used at PSG.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01210261
Start Date
May 1 2011
End Date
October 1 2011
Last Update
April 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Respiratory & Sleep Medicine, Monash Medical Centre
Clayton, Victoria, Australia, 3168